5-Alpha Reductase and Anabolic Effects of Testosterone
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Safety and Efficacy of Sugammadex (Org 25969, MK-8616) in Participants With or Having a Past History of Pulmonary Disease (19.4.308) (P05932) (MK-8616-017)
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of the Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616; Org 25969) in Elderly Participants With Adult Participants (MK-8616-029)
- Status
- COMPLETED
- Phase
- PHASE3
Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Recovery From Rocuronium 1.2 mg/kg Followed by Sugammadex (Org 25969) 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)(MK-8616-026)
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025)
- Status
- COMPLETED
- Phase
- PHASE3
Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to Peroxidation
- Status
- COMPLETED
- Phase
- PHASE4
A Study of V950 in People With Alzheimer Disease (V950-001 AM7)
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Combination Therapy: Montelukast and Inhaled Steroid on Exercise Induced Bronchoconstriction
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both
- Status
- COMPLETED
- Phase
- NA
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT
- Status
- UNKNOWN
- Phase
- N/A
High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load
- Status
- COMPLETED
- Phase
- PHASE3
Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Sugammadex (Org 25969) With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (P05960)
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931)
- Status
- COMPLETED
- Phase
- PHASE3